Literature DB >> 15270749

Helicobacter pylori infection and immune thrombocytopenic purpura: an update.

Massimo Franchini1, Dino Veneri.   

Abstract

Data are accumulating on the association between Helicobacter pylori infection and idiopathic thrombocytopenic purpura (ITP) and the significant increase in platelet count after bacterial eradication. The aim of this review was to consider the studies so far published on H. pylori infection and ITP in order to evaluate a possible correlation between these two conditions. A review of the literature showed that 278 out of the 482 ITP patients investigated (58%) were positive for H. pylori infection and that the bacterium was eradicated in 88% of cases. Eradication therapy was accompanied by a complete or partial platelet response in approximately half the cases. Overall, these data show that H. pylori eradication in patients with ITP is effective in increasing platelet count. However, because the studies so far published are few, are sometimes controversial and involve small series of patients, further studies on larger numbers of patients with longer follow-up are needed to confirm these preliminary findings.

Entities:  

Mesh:

Year:  2004        PMID: 15270749     DOI: 10.1111/j.1083-4389.2004.00238.x

Source DB:  PubMed          Journal:  Helicobacter        ISSN: 1083-4389            Impact factor:   5.753


  14 in total

1.  Internalization of IgG-coated targets results in activation and secretion of soluble CD40 ligand and RANTES by human platelets.

Authors:  Adam J Antczak; Joshua A Vieth; Navinderjit Singh; Randall G Worth
Journal:  Clin Vaccine Immunol       Date:  2010-12-22

Review 2.  Helicobacter pylori Eradication in Patients with Immune Thrombocytopenic Purpura: A Review and the Role of Biogeography.

Authors:  Galit H Frydman; Nick Davis; Paul L Beck; James G Fox
Journal:  Helicobacter       Date:  2015-03-01       Impact factor: 5.753

3.  The relationship between immune thrombocytopenic purpura and Helicobacter pylori infection in children: where is the truth?

Authors:  Giuseppe Loffredo; Maria Grazia Marzano; Roberta Migliorati; Erasmo Miele; Francesco Menna; Vincenzo Poggi; Annamaria Staiano
Journal:  Eur J Pediatr       Date:  2006-11-29       Impact factor: 3.183

Review 4.  Consequences of Helicobacter pylori infection in children.

Authors:  Lucia Pacifico; Caterina Anania; John F Osborn; Flavia Ferraro; Claudio Chiesa
Journal:  World J Gastroenterol       Date:  2010-11-07       Impact factor: 5.742

5.  Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report.

Authors:  P Malfertheiner; F Megraud; C O'Morain; F Bazzoli; E El-Omar; D Graham; R Hunt; T Rokkas; N Vakil; E J Kuipers
Journal:  Gut       Date:  2006-12-14       Impact factor: 23.059

6.  Human platelets efficiently kill IgG-opsonized E. coli.

Authors:  Anum H Riaz; Brian E Tasma; Michael E Woodman; R Mark Wooten; Randall G Worth
Journal:  FEMS Immunol Med Microbiol       Date:  2012-03-20

Review 7.  Helicobacter pylori infection and idiopathic thrombocytopenic purpura.

Authors:  Kingo Fujimura
Journal:  Int J Hematol       Date:  2005-02       Impact factor: 2.490

Review 8.  The role of autoreactive T-cells in the pathogenesis of idiopathic thrombocytopenic purpura.

Authors:  Masataka Kuwana; Yasuo Ikeda
Journal:  Int J Hematol       Date:  2005-02       Impact factor: 2.490

9.  Long term platelet responses to Helicobacter pylori eradication in Canadian patients with immune thrombocytopenic purpura.

Authors:  Shannon C Jackson; Paul Beck; Andre G Buret; Pamela M O'Connor; Jonathan Meddings; Graham Pineo; Man-Chiu Poon
Journal:  Int J Hematol       Date:  2008-08-01       Impact factor: 2.490

Review 10.  What is new in the management of Helicobacter pylori?

Authors:  B J Egan; H J O'Connor; C A O'Morain
Journal:  Ir J Med Sci       Date:  2008-07-18       Impact factor: 1.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.